These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33558914)

  • 1. Formulation and Evaluation of Multidose Propofol Nanoemulsion Using Statistically Designed Experiments.
    Hota SS; Pattnaik S; Mallick S
    Acta Chim Slov; 2020 Mar; 67(1):179-188. PubMed ID: 33558914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical properties and stability of two emulsion formulations of propofol.
    Han J; Davis SS; Washington C
    Int J Pharm; 2001 Mar; 215(1-2):207-20. PubMed ID: 11250106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions.
    Wang C; Wang S; Wu C; Lei L; Wang DX; Zhang Q
    Pharmacology; 2021; 106(11-12):644-657. PubMed ID: 34644710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex.
    Xia XJ; Guo RF; Liu YL; Zhang PX; Zhou CP; Jin DJ; Wang RY
    Chem Pharm Bull (Tokyo); 2011; 59(3):321-6. PubMed ID: 21372412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured Lipid Carrier of Propofol: a Promising Alternative to Marketed Soybean Oil-Based Nanoemulsion.
    Shevalkar G; Pai R; Vavia P
    AAPS PharmSciTech; 2019 May; 20(5):201. PubMed ID: 31139968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol: the challenges of formulation.
    Baker MT; Naguib M
    Anesthesiology; 2005 Oct; 103(4):860-76. PubMed ID: 16192780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery.
    Müller RH; Harden D; Keck CM
    Drug Dev Ind Pharm; 2012 Apr; 38(4):420-30. PubMed ID: 22088169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of microemulsions for improved parenteral delivery of propofol.
    Date AA; Nagarsenker MS
    AAPS PharmSciTech; 2008; 9(1):138-45. PubMed ID: 18446474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Quercetin loaded Palm Oil Ester Based Nanoemulsion Formulation for Pulmonary Delivery.
    Arbain NH; Salim N; Wui WT; Basri M; Rahman MBA
    J Oleo Sci; 2018 Aug; 67(8):933-940. PubMed ID: 30012897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E.
    Lu Y; Wang Y; Tang X
    Int J Pharm; 2008 Jan; 346(1-2):47-56. PubMed ID: 17640833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, preparation and evaluation of an intravenous emulsion containing Brucea javanica oil and Coix Seed oil for anti-tumor application.
    Yu YL; Lu Y; Tang X; Cui FD
    Biol Pharm Bull; 2008 Apr; 31(4):673-80. PubMed ID: 18379061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization.
    Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q
    Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.
    Damitz R; Chauhan A
    Int J Pharm; 2015; 486(1-2):232-41. PubMed ID: 25839419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of oil droplets and lipid vesicles in propofol drug products.
    Wu Y; Manna S; Petrochenko P; Koo B; Chen L; Xu X; Choi S; Kozak D; Zheng J
    Int J Pharm; 2020 Mar; 577():118998. PubMed ID: 31935473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid dissolution of propofol emulsions under sink conditions.
    Damitz R; Chauhan A
    Int J Pharm; 2015 Mar; 481(1-2):47-55. PubMed ID: 25636303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.
    Altaani BM; Almaaytah AM; Dadou S; Alkhamis K; Daradka MH; Hananeh W
    Pharm Res; 2020 Apr; 37(4):80. PubMed ID: 32253527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite.
    Baker MT; Gregerson MS; Martin SM; Buettner GR
    Crit Care Med; 2003 Mar; 31(3):787-92. PubMed ID: 12626985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a compounded propofol nanoemulsion using multiple non-invasive process analytical technologies.
    Rooimans T; Damen M; Markesteijn CMA; Schuurmans CCL; de Zoete NHC; van Hasselt PM; Hennink WE; van Nostrum CF; Hermes M; Besseling R; Vromans H
    Int J Pharm; 2023 Jun; 640():122960. PubMed ID: 37061210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the addition of lignocaine on propofol emulsion stability.
    Lilley EM; Isert PR; Carasso ML; Kennedy RA
    Anaesthesia; 1996 Sep; 51(9):815-8. PubMed ID: 8882240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.